drugset / Trial / NCT04667247
RCT of Fomitopsis Officinalis and Trametes Versicolor to Treat COVID-19
Phase 1/2
Completed
54 enrolled
Gordon Saxe
University of California, Irvine · collabUniversity of California, Los Angeles · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a multi-center, randomized, double-blind, placebo-controlled clinical trial to evaluate two polypore mushrooms, Fomitopsis officinalis and Trametes versicolor (FoTv), to treat COVID-19-positive outpatients with mild-to-moderate symptoms assigned to self-quarantined and home management. The study aims to establish the safety and feasibility of the use of FoTv vs placebo in 66 total subjects.
Timeline
- Start
- 2020-12-23
- Primary completion
- 2022-03-21
- Completion
- 2022-05-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fomitopsis officinalis | Unknown | — | — |
| Subject | Trametes versicolor | Unknown | — | — |